Pancreatic Cancer Research

ResearcherDalhousie UniversityActive in the last 2 years

Thomas Arnason

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5038-6202; OpenAlex author ID A5053845155. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 6

  1. Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. Co-author DOI 10.1136/jitc-2025-013796↗
  2. Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol33020088↗
  3. Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy. Last author DOI 10.1016/j.tranon.2025.102362↗
  4. Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1730817↗
  5. Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian Population. Last author DOI 10.3390/jcm13226893↗
  6. PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Co-author DOI 10.3390/jcm11144241↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ravi Ramjeesingh · 4 shared papers, 2024–2026 · strength 1.13
  2. Jeanette E. Boudreau · 4 shared papers, 2022–2026 · strength 1.07
  3. Riley J. Arseneau · 3 shared papers, 2025–2026 · strength 0.94
  4. Carley Bekkers · 3 shared papers, 2024–2025 · strength 0.87
  5. Stacey N. Lee · 3 shared papers, 2022–2026 · strength 0.81
  6. Boris Gala-López · 3 shared papers, 2025–2026 · strength 0.77
  7. Thomas Samson · 3 shared papers, 2025–2026 · strength 0.77
  8. Sharon E. Clarke · 1 shared paper, 2026 · strength 0.26
  9. Ryan C. DeCoste · 1 shared paper, 2022 · strength 0.14
  10. Weei‐Yuarn Huang · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.